{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T21:15:13Z","timestamp":1774473313531,"version":"3.50.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1097\/iop.0b013e31824ee702","type":"journal-article","created":{"date-parts":[[2012,7,11]],"date-time":"2012-07-11T10:35:57Z","timestamp":1342002957000},"page":"256-260","source":"Crossref","is-referenced-by-count":26,"title":["Botulinum Toxin-A\u2013Induced Protective Ptosis in the Treatment of Lagophthalmos Associated With Facial Paralysis"],"prefix":"10.1097","volume":"28","author":[{"given":"\u00d6zlem E\u015fki","family":"Y\u00fccel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur\u015fen","family":"Arit\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-5-20210129","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0094-1298(20)32045-9","article-title":"The evaluation and management of the eye in facial palsy.","volume":"6","author":"Jelks","year":"1979","journal-title":"Clin Plast Surg"},{"key":"R4-5-20210129","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00003226-200111000-00002","article-title":"Tarsorrhaphy: clinical experience from a cornea practice.","volume":"20","author":"Cosar","year":"2001","journal-title":"Cornea"},{"key":"R5-5-20210129","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.prs.0000254346.19507.e8","article-title":"Outcomes of periocular reconstruction for facial nerve paralysis in cancer patients.","volume":"119","author":"Golio","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"R6-5-20210129","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/019459989411000305","article-title":"Primary surgical management for rehabilitation of the paralyzed eye.","volume":"110","author":"Maas","year":"1994","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R7-5-20210129","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/00006534-200003000-00005","article-title":"Upper eyelid gold weight implantation in the Asian patient with facial paralysis.","volume":"105","author":"Choo","year":"2000","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"R8-5-20210129","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.iop.0000235817.78695.6f","article-title":"Techniques for upper eyelid loading.","volume":"22","author":"Ioannis","year":"2006","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R9-5-20210129","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1442-9071.2001.d01-28.x","article-title":"An evaluation of the safety and efficacy of botulinum toxin type A (BOTOX) when used to produce a protective ptosis.","volume":"29","author":"Ellis","year":"2001","journal-title":"Clin Exp Ophthalmol"},{"key":"R10-5-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.survophthal.2006.10.003","article-title":"Botulinum toxin in ophthalmology.","volume":"52","author":"Dutton","year":"2007","journal-title":"Surv Ophthalmol"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/01676830490512233","article-title":"Treatment of aberrant facial nerve regeneration with botulinum toxin A.","volume":"23","author":"Chua","year":"2004","journal-title":"Orbit"},{"key":"R12-5-20210129","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1097\/01.PRS.0000160265.18780.1C","article-title":"The phenomenon of the late recovered Bells palsy: treatment options to improve facial symmetry.","volume":"115","author":"Bulstrode","year":"2005","journal-title":"Plast Reconstr Surg"},{"key":"R13-5-20210129","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/14764170310021913","article-title":"Use of botulinum toxin in facial paralysis.","volume":"5","author":"Maio","year":"2003","journal-title":"J Cosmetic Laser Ther"},{"key":"R14-5-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-0404.2006.00746.x","article-title":"Low-dose subcutaneous injection of botulinum toxin type A for facial synkinesis and hyperlacrimation.","volume":"115","author":"Ito","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"R15-5-20210129","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/jnnp.65.1.111","article-title":"Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy.","volume":"65","author":"Boroojerdi","year":"1998","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"R16-5-20210129","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ajo.2004.09.035","article-title":"Contralateral botulinum injections improve drinking ability and facial symmetry in patients with facial paralysis.","volume":"139","author":"Krohel","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R18-5-20210129","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/01.mlg.0000225980.38147.c6","article-title":"Multimodality approach to management of the paralyzed face.","volume":"116","author":"Hadlock","year":"2006","journal-title":"Laryngoscope"},{"key":"R19-5-20210129","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0266-4356(95)90210-4","article-title":"Protective ptosis after parotid surgery induced with botulinum toxin.","volume":"33","author":"Smyth","year":"1995","journal-title":"Br J Oral Maxillofac Surg"},{"key":"R23-5-20210129","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0161-6420(88)33163-5","article-title":"Botulinum toxin A-induced protective ptosis in corneal disease.","volume":"95","author":"Kirkness","year":"1988","journal-title":"Ophthalmology"},{"key":"R24-5-20210129","first-page":"383","article-title":"Temporary tarsorrhaphy induced with type A botulinum toxin.","volume":"26","author":"Wuebbolt","year":"1991","journal-title":"Can J Ophthalmol"},{"issue":"Supplement","key":"R25-5-20210129","first-page":"30","article-title":"Two methods of inducing protective ptosis with Botulinum toxins. A comparison.","volume":"139","author":"Chua","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R26-5-20210129","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/sj.eye.6702866","article-title":"Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection.","volume":"22","author":"Naik","year":"2008","journal-title":"Eye (Lond)"},{"key":"R27-5-20210129","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/IOP.0b013e3181d8e150","article-title":"Abobotulinum toxin A (Dysport) and botulinum toxin type A (Botox) for purposeful induction of eyelid ptosis.","volume":"26","author":"Reddy","year":"2010","journal-title":"Ophthal Plast Reconstr Surg"}],"container-title":["Ophthalmic Plastic & Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IOP.0b013e31824ee702","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:50:20Z","timestamp":1620957020000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002341-201207000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/iop.0b013e31824ee702","relation":{},"ISSN":["0740-9303"],"issn-type":[{"value":"0740-9303","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}